Change of telomere length in angiotensin II-induced human glomerular mesangial cell senescence and the protective role of losartan

被引:28
作者
Feng, Xin [1 ]
Wang, Lining [1 ]
Li, Yao [2 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Dept Nephropathy, Shenyang 110001, Liaoning, Peoples R China
[2] Liaoning Med Univ, Dept Physiol, Jinzhou 121000, Liaoning, Peoples R China
关键词
senescence; angiotensin II; telomere length; losartan; OXIDATIVE STRESS; ENALAPRIL; AGE;
D O I
10.3892/mmr.2011.436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomeres are DNA repeats at the ends of linear chromosomes in eukaryotic cells; they form cap-like specialized structures at chromosome ends to protect them from digestion and degradation. With each cell division, somatic cell telomeres progressively wear and shorten, leading to cell senescence. Various environmental factors, such as oxidative stress and in can accelerate telomere shortening. The renin angiotensin system seems to be the key mechanism involved in aging. Our previous studies demonstrated that treatment of human glomerular mesangial cells (GMCs) with angiotensin II (AngII.) caused cell senescence. It is important to understand whether AngII accelerates telomere shortening in GMCs and further promotes aging. Therefore, this study was designed to investigate the change in telomere length in AngII-induced GMC senescence and the role of the AngII receptor antagonist losartan in delaying this process. The cells were synchronized and divided into a normal control group, an AngII group (AngII, 10(-6) mol/l) and an AngII + losartan group (losartan, 10(-5) mol/l), and were then cultured for 72 If. The telomere lengths were analyzed by Southern blot analysis, cell morphology was monitored, the cell cycle and beta-galactosidase staining were determined, and the expression of P53 and P21 proteins was assessed by Western blotting. Compared with the control group, the AngII group exhibited a markedly reduced telomere length, cell cycle arrest, enhanced beta-galactosidase staining, and elevated expression of P53 and P21. The AngII + losartan group displayed longer telomere lengths, further reduced beta-galactosidase staining and decreased P53 and P21 expression compared to the AngII group. This study confirms that AngIl induces the shortening of telomere lengths, P53 and P21 expression, cell cycle arrest, and the resulting cell senescence in GMCs. In addition, losartan significantly reduced telomere shortening and cell senescence.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 24 条
[1]   TANDEMLY REPEATED SEQUENCE AT TERMINI OF EXTRACHROMOSOMAL RIBOSOMAL-RNA GENES IN TETRAHYMENA [J].
BLACKBURN, EH ;
GALL, JG .
JOURNAL OF MOLECULAR BIOLOGY, 1978, 120 (01) :33-53
[2]   Switching and signaling at the telomere [J].
Blackburn, EH .
CELL, 2001, 106 (06) :661-673
[3]   Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues [J].
De Cavanagh, EMV ;
Inserra, F ;
Ferder, L ;
Fraga, CG .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 278 (03) :R572-R577
[4]   Enalapril and losartan attenuate mitochondrial dysfunction in aged rats [J].
de Cavanagh, EMV ;
Piotrkowski, B ;
Basso, N ;
Stella, I ;
Inserra, F ;
Ferder, L ;
Fraga, CG .
FASEB JOURNAL, 2003, 17 (06) :1096-+
[5]   Molecular events in kidney ageing [J].
Famulski, KS ;
Halloran, PF .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2005, 14 (03) :243-248
[6]   Viral oncogenes accelerate conversion to immortality of cultured conditionally immortal human mammary epithelial cells [J].
Garbe, J ;
Wong, M ;
Wigington, D ;
Yaswen, P ;
Stampfer, MR .
ONCOGENE, 1999, 18 (13) :2169-2180
[7]  
Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864
[8]   The free radical theory of aging [J].
Harman, D .
ANTIOXIDANTS & REDOX SIGNALING, 2003, 5 (05) :557-561
[9]   Pioglitazone inhibits angiotensin II-induced senescence of endothelial progenitor cell [J].
Imanishi, Toshio ;
Kobayashi, Katsunobu ;
Kuroi, Akio ;
Ikejima, Hideyuki ;
Akasaka, Takashi .
HYPERTENSION RESEARCH, 2008, 31 (04) :757-765
[10]  
JANAKIRAMAN K, 2004, J CLIN INVEST, V114, P1299